Patient disposition and impact of hematological response on overall survival following stem cell transplantation. (A) Number of patients surviving at least 100 days after transplantation and those evaluable for hematologic and cardiac responses. (B) Kaplan-Meier curves comparing OS between patients with HR and those with no HR. The median OS for patients with (n = 124) and without (n = 33) an HR was 98 months (95% CI, 70 [NR]) and 28 months (95% CI, 14-42), respectively (P < .001). (C) Kaplan-Meier curves comparing TTNT between patients with HR and those with no HR. The median TTNT was 62 months for the responders compared with 24 months (95% CI, 15 [NR]) for those with no hematologic PR (P < .001). (D) Kaplan-Meier curves comparing OS between patients with CR and those with no CR. The median OS for patients with (n = 56) and without (n = 101) a CR was NR (95% CI, 98 [NR]) and 45 months (95% CI, 33-69), respectively (P < .001).